Literature DB >> 8635684

Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies.

K P Ponder1.   

Abstract

The mechanism of generating new hepatocytes and bile ductule cells in the liver has been controversial. Oval cells are found in the periportal region under some circumstances and may represent multipotent stem cells. The role of stem cells in generating new liver cells in normal and pathological conditions is unclear, however. Genetic marking can be used to determine the ability of a particular cell to replicate and to migrate. Cells of known lineage are marked at an initial time point, and their developmental potential determined by the cluster size, position, and phenotype of marked cells at a later time point. Recently, genetic marking studies have demonstrated that the hepatocyte itself is the source of new hepatocytes in the normal postnatal liver and that daughter cells do not migrate. These studies have also demonstrated that the hepatocyte can replicate extensively when stimulated. Finally, genetic marking studies suggest that either hepatocytes or oval cells can develop into a hepatocellular carcinoma or cholangiocarcinoma if a sufficient number of genetic mutations accumulate. The implications of these results for hepatic gene therapy, treatment of liver insufficiency states, and liver cancer are discussed. Future genetic marking studies may help to address some remaining questions in liver biology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635684     DOI: 10.1096/fasebj.10.7.8635684

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

Review 1.  The many ways to mend your liver: A critical appraisal.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2018-06-07       Impact factor: 1.925

Review 2.  Stem cells versus plasticity in liver and pancreas regeneration.

Authors:  Janel L Kopp; Markus Grompe; Maike Sander
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

3.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.

Authors:  Dawang Zhou; Yongyou Zhang; Hongtan Wu; Evan Barry; Yi Yin; Earl Lawrence; Dawn Dawson; Joseph E Willis; Sanford D Markowitz; Fernando D Camargo; Joseph Avruch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

4.  Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity.

Authors:  T Imai; M Jiang; P Kastner; P Chambon; D Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

5.  FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration.

Authors:  Hinako M Takase; Tohru Itoh; Seitaro Ino; Ting Wang; Takehiko Koji; Shizuo Akira; Yasuhiro Takikawa; Atsushi Miyajima
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

6.  Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.

Authors:  Mindy Tittiger; Xiucui Ma; Lingfei Xu; Katherine P Ponder
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

Review 7.  MST1/MST2 Protein Kinases: Regulation and Physiologic Roles.

Authors:  Jacob A Galan; Joseph Avruch
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

Review 8.  Stem cells and liver regeneration.

Authors:  Andrew W Duncan; Craig Dorrell; Markus Grompe
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

Review 9.  Pluripotent stem cells and their niches.

Authors:  M William Lensch; Laurence Daheron; Thorsten M Schlaeger
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 10.  Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.

Authors:  J Avruch; D Zhou; J Fitamant; N Bardeesy
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.